Maternal serum interleukin-33 and soluble ST2 across early pregnancy, and their association with miscarriage

Journal of Reproductive Immunology

Volumn 95, Issue 1-2, 2012, Pages 46-49

  Kaitu'u Lino, Tu'uhevaha J ^a   Tuohey, Laura ^a   Tong, Stephen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

IL 33; Miscarriage; Pregnancy; Serum; SST2

Indexed keywords

CELL RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 33; ST2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL WELL BEING; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; EMBRYO IMPLANTATION; FEMALE; HUMANS; INTERLEUKINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, CELL SURFACE;

EID: 84865571610     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.06.003     Document Type: Article

References (8)

1. Chaouat G., et al. Th1/Th2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the Th1/Th2 paradigm. Int. Arch. Allergy Immunol. 2004, 134:93-119.
2. Dimitriadis E., et al. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum. Reprod. Update 2005, 11:613-630.
3. Granne I., et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One 2012, 6:e24463.
4. Kakkar R., Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 2008, 7:827-840.
5. Mildner M., et al. Primary sources and immunological prerequisites for sst2 secretion in humans. Cardiovasc. Res. 2010, 87:769-777.
6. Tong S., et al. Miscarriage risk for asymptomatic women after a normal first-trimester prenatal visit. Obstet. Gynecol. 2008, 111:710-714.
7. Tong S., et al. The diagnostic accuracy of maternal serum mic-1 and papp-a at 6-10 weeks to predict miscarriage. Obstet. Gynecol. 2012, 119:1000-1008.
8. Xu D., et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 1998, 187:787-794.